Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 22863657)

1.

Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.

Bowen DM, Lewis JA, Lu W, Schein CH.

Vaccine. 2012 Sep 14;30(42):6081-7. doi: 10.1016/j.vaccine.2012.07.042. Epub 2012 Jul 31.

2.

Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals.

Schein CH, Bowen DM, Lewis JA, Choi K, Paul A, van der Heden van Noort GJ, Lu W, Filippov DV.

BMC Bioinformatics. 2012;13 Suppl 13:S9. doi: 10.1186/1471-2105-13-S13-S9. Epub 2012 Aug 24.

3.

The human antibody response to dengue virus infection.

Wahala WM, Silva AM.

Viruses. 2011 Dec;3(12):2374-95. doi: 10.3390/v3122374. Epub 2011 Nov 25. Review.

4.

Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.

Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE Jr.

J Virol. 2014 Nov;88(21):12233-41. doi: 10.1128/JVI.00247-14. Epub 2014 Aug 6.

5.

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.

6.

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.

7.

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Brien JD, Austin SK, Sukupolvi-Petty S, O'Brien KM, Johnson S, Fremont DH, Diamond MS.

J Virol. 2010 Oct;84(20):10630-43. doi: 10.1128/JVI.01190-10. Epub 2010 Aug 11.

8.

PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Danecek P, Lu W, Schein CH.

J Mol Biol. 2010 Feb 26;396(3):550-63. doi: 10.1016/j.jmb.2009.11.070. Epub 2009 Dec 4.

9.

Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.

Yamanaka A, Suzuki R, Konishi E.

Vaccine. 2014 Jul 23;32(34):4289-95. doi: 10.1016/j.vaccine.2014.06.017. Epub 2014 Jun 17.

PMID:
24950360
10.

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.

de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1188. doi: 10.1371/journal.pntd.0001188. Epub 2011 Jun 21. Erratum in: PLoS Negl Trop Dis. 2011 Aug;5(8). doi: 10.1371/annotation/f585335f-ff77-40ae-a8b6-ad6019af31aa. Brian, James [corrected to Brien, James D].

11.

Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.

Sasaki T, Setthapramote C, Kurosu T, Nishimura M, Asai A, Omokoko MD, Pipattanaboon C, Pitaksajjakul P, Limkittikul K, Subchareon A, Chaichana P, Okabayashi T, Hirai I, Leaungwutiwong P, Misaki R, Fujiyama K, Ono K, Okuno Y, Ramasoota P, Ikuta K.

Antiviral Res. 2013 Jun;98(3):423-31. doi: 10.1016/j.antiviral.2013.03.018. Epub 2013 Mar 29.

PMID:
23545366
12.

Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Crill WD, Hughes HR, Delorey MJ, Chang GJ.

PLoS One. 2009;4(4):e4991. doi: 10.1371/journal.pone.0004991. Epub 2009 Apr 1.

13.

Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.

Lisova O, Belkadi L, Bedouelle H.

J Mol Recognit. 2014 Apr;27(4):205-14. doi: 10.1002/jmr.2352.

PMID:
24591178
14.

Natural strain variation and antibody neutralization of dengue serotype 3 viruses.

Wahala WM, Donaldson EF, de Alwis R, Accavitti-Loper MA, Baric RS, de Silva AM.

PLoS Pathog. 2010 Mar 19;6(3):e1000821. doi: 10.1371/journal.ppat.1000821.

15.

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient.

Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE.

Virol J. 2010 Feb 4;7:28. doi: 10.1186/1743-422X-7-28.

16.

The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O'Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS.

PLoS Pathog. 2010 Apr 1;6(4):e1000823. doi: 10.1371/journal.ppat.1000823.

17.

Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein.

Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L, Cai J, Che X.

Clin Vaccine Immunol. 2012 Jan;19(1):73-8. doi: 10.1128/CVI.05388-11. Epub 2011 Nov 23.

18.

On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.

Rajamanonmani R, Nkenfou C, Clancy P, Yau YH, Shochat SG, Sukupolvi-Petty S, Schul W, Diamond MS, Vasudevan SG, Lescar J.

J Gen Virol. 2009 Apr;90(Pt 4):799-809. doi: 10.1099/vir.0.006874-0. Epub 2009 Mar 4.

19.
20.

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS.

J Virol. 2010 Sep;84(18):9227-39. doi: 10.1128/JVI.01087-10. Epub 2010 Jun 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk